<DOC>
	<DOCNO>NCT00598897</DOCNO>
	<brief_summary>To determine safety tolerance clarithromycin give three time per week combination multiple drug include rifabutin three time per week</brief_summary>
	<brief_title>Use Clarithromycin Rifabutin Treatment M. Avium Complex ( MAC ) Lung Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Mycobacterium avium-intracellulare Infection</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Rifabutin</mesh_term>
	<criteria>Meet American Thoracic Society criterion nontuberculous mycobacterial lung disease : two AFB smear positive , culture positive sputum bronchoscopic sample and/or two AFB smear negative respiratory sample moderate heavy growth ( 2+4+ ) ; abnormal CXR consistent M. avium lung disease ; absence potential mycobacterial fungal lung pathogen ( except coexistence M. abscessus ) . Adults age 18 old Pretreatment isolate M. avium complex available MIC determination History allergy study drug If mensruating female , pregnant adequate birth control . Children le 18 year age HIV + high risk HIV infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>MAC</keyword>
</DOC>